Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1950 of 2529 entries
View as:

A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Phase: N/A Priority: Normal
NCT ID: NCT04847596 Org: User:
Start: 05/21/21 End: 02/18/22 Due: 02/18/23

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01213641 Org: User:
Start: 11/30/09 End: 12/31/15 Due: 12/31/16

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

Phase: N/A Priority: Normal
NCT ID: NCT04930094 Org: User:
Start: 10/06/21 End: 07/05/27 Due: 07/05/28

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01004224 Org: User:
Start: 12/11/09 End: 10/08/18 Due: 10/08/19

Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00748189 Org: User:
Start: 12/22/08 End: 05/17/18 Due: 05/17/19

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Phase: N/A Priority: Normal
NCT ID: NCT00680901 Org: User:
Start: 06/04/08 End: 10/03/24 Due: 10/03/25

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00050011 Org: User:
Start: 09/30/02 End: 01/31/09 Due: 01/31/10

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00107926 Org: User:
Start: 10/31/04 End: 08/31/07 Due: 08/31/08

Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02756663 Org: User:
Start: 12/31/16 End: 02/28/21 Due: 02/28/22

PD of VAY736 in Patients With Primary Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02149420 Org: User:
Start: 05/23/14 End: 02/07/18 Due: 02/07/19

De-escalation and TFR Study in CML Patients Treated With Nilotinib Followed by a Second Attempt After Nilotinib and Asciminib Combination

Phase: N/A Priority: Normal
NCT ID: NCT03874858 Org: User:
Start: 03/22/19 End: 12/31/26 Due: 12/31/27

Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT01663233 Org: User:
Start: 08/31/12 End: 05/31/13 Due: 05/31/14

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT00560820 Org: User:
Start: 09/30/07 End: 04/30/12 Due: 04/30/13

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01811472 Org: User:
Start: 06/30/13 End: 09/30/14 Due: 09/30/15

A Prospective, Open Label Study of CERtican in KIdney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01594268 Org: User:
Start: 03/31/12 End: 10/31/13 Due: 10/31/14

Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

Phase: N/A Priority: Normal
NCT ID: NCT03158311 Org: User:
Start: 02/05/18 End: 07/19/19 Due: 07/19/20

A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.

Phase: N/A Priority: Normal
NCT ID: NCT00154336 Org: User:
Start: 07/31/04 End: 08/31/05 Due: 08/31/06

Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00876395 Org: User:
Start: 09/10/09 End: 10/23/17 Due: 10/23/18

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01807520 Org: User:
Start: 06/20/13 End: 01/03/17 Due: 01/03/18

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00219271 Org: User:
Start: 09/30/03 End: 09/30/09 Due: 09/30/10

Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib

Phase: N/A Priority: Normal
NCT ID: NCT01478373 Org: User:
Start: 01/31/12 End: 07/31/14 Due: 07/31/15

The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss

Phase: N/A Priority: Normal
NCT ID: NCT00375505 Org: User:
Start: 10/31/05 End: 05/31/14 Due: 05/31/15

Managed Access Programs for LNP023, Iptacopan

Phase: N/A Priority: Normal
NCT ID: NCT05222412 Org: User:
Start: - End: - Due: -

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

Phase: N/A Priority: Normal
NCT ID: NCT05096143 Org: User:
Start: 06/03/20 End: 10/19/20 Due: 10/19/21

CTL019 Out of Specification MAP for ALL or DLBCL Patients

Phase: N/A Priority: Normal
NCT ID: NCT03601442 Org: User:
Start: - End: - Due: -